WO2007034009A3 - Utilización de acido masónico como antiparasitario frente a protozoos del phyllum apicomplexa - Google Patents
Utilización de acido masónico como antiparasitario frente a protozoos del phyllum apicomplexa Download PDFInfo
- Publication number
- WO2007034009A3 WO2007034009A3 PCT/ES2006/000500 ES2006000500W WO2007034009A3 WO 2007034009 A3 WO2007034009 A3 WO 2007034009A3 ES 2006000500 W ES2006000500 W ES 2006000500W WO 2007034009 A3 WO2007034009 A3 WO 2007034009A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protozoans
- maslinic acid
- agent against
- phylum apicomplexa
- antiparasitic agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
El ácido 2-alfa,3-betadihidroxi-28-carboxiolean-12-eno (ácido maslí nico), sus sales y derivados se utilizan como inhibidores de serin-proteasas para la obtención de preparados destinados al tratamiento y prevención de parasitosis causadas en humanos y animales por las especies del phyllum Apicomplexa: Eimeria, Toxoplasma, Neospora, Cyclospora, Isospora, Besnoisia, Babesia y Plasmodium.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ESP200502349 | 2005-09-20 | ||
ES200502349A ES2282027B1 (es) | 2005-09-20 | 2005-09-20 | Utilizacion de acido maslinico como antiparasitario frente a protozoos del phyllum apicomplexa. |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007034009A2 WO2007034009A2 (es) | 2007-03-29 |
WO2007034009A3 true WO2007034009A3 (es) | 2007-08-02 |
Family
ID=37889164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ES2006/000500 WO2007034009A2 (es) | 2005-09-20 | 2006-09-04 | Utilización de acido masónico como antiparasitario frente a protozoos del phyllum apicomplexa |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR055642A1 (es) |
ES (1) | ES2282027B1 (es) |
WO (1) | WO2007034009A2 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101619088B (zh) * | 2009-08-04 | 2012-07-04 | 上海朴颐化学科技有限公司 | 山楂酸衍生物及其制备和应用 |
ES2392522A1 (es) * | 2011-05-28 | 2012-12-11 | Universidad De La Laguna | Composición para el mantenimiento de lentes de contacto que resulta efectiva frente a acanthamoeba ssp. |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997012582A2 (en) * | 1995-10-06 | 1997-04-10 | Agrimmune, Inc. | Method for preventing and treating coccidiosis |
ES2131467A1 (es) * | 1997-05-12 | 1999-07-16 | Univ Granada | Utilizacion de acido maslinico como inhibidor de serin-proteasas para el tratamiento de enfermedades causadas por parasitos del genero cryptosporidium. |
WO2005034838A2 (en) * | 2002-05-22 | 2005-04-21 | Smithkline Beecham Corporation | Protease inhibitors |
-
2005
- 2005-09-20 ES ES200502349A patent/ES2282027B1/es active Active
-
2006
- 2006-09-04 WO PCT/ES2006/000500 patent/WO2007034009A2/es active Application Filing
- 2006-09-19 AR ARP060104104A patent/AR055642A1/es unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997012582A2 (en) * | 1995-10-06 | 1997-04-10 | Agrimmune, Inc. | Method for preventing and treating coccidiosis |
ES2131467A1 (es) * | 1997-05-12 | 1999-07-16 | Univ Granada | Utilizacion de acido maslinico como inhibidor de serin-proteasas para el tratamiento de enfermedades causadas por parasitos del genero cryptosporidium. |
WO2005034838A2 (en) * | 2002-05-22 | 2005-04-21 | Smithkline Beecham Corporation | Protease inhibitors |
Also Published As
Publication number | Publication date |
---|---|
ES2282027A1 (es) | 2007-10-01 |
AR055642A1 (es) | 2007-08-29 |
WO2007034009A2 (es) | 2007-03-29 |
ES2282027B1 (es) | 2008-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007147019A3 (en) | Il-17 and il-23 antagonists and methods of using the same | |
WO2006138418A3 (en) | Improvement of cognitive performance with sirtuin activators | |
EP4233892A3 (en) | Stable anti-ifnar1 formulation | |
WO2006084131A3 (en) | Furin inhibitors and alpha-defensins for the treatment or prevention of papillomavirus infection | |
WO2008144015A3 (en) | Bioactive agrichemical compositions and use thereof | |
WO2005007115A3 (en) | Pharmaceutical composition for inhibiting acid secretion | |
CY1113834T1 (el) | Υγρο παρασκευασμα αυξητικης ορμονης | |
WO2007115305A3 (en) | Oral dosage forms including an antiplatelet agent and an acid inhibitor | |
IL193274A0 (en) | Pharmaceutical formulation for aerosols, comprising two or more active agents and at least one surfactant | |
WO2009073569A3 (en) | Protein formulations and methods of making same | |
WO2011008495A3 (en) | Arginase formulations and methods | |
MX2015015152A (es) | Formulaciones de anticuerpos biespecificos anti-il-4/anti-il-13. | |
FI3834841T3 (fi) | Stabiloituja neste- ja lyofilisoituja ADAMTS13-formulaatioita | |
WO2010000744A3 (en) | Use of cationic surfactants as sporicidal agents | |
WO2005074925A8 (en) | Compositions substantially free of galactomannan containing piperacillin and tazobactam | |
WO2011089062A3 (en) | Pharmaceutical formulation for proteins | |
WO2018109588A3 (en) | Stable aqueous anti-c5 antibody composition | |
WO2004085682A3 (de) | Caspase inhibitoren, insbesondere von caspase-3, zur behandlung von influenza | |
WO2012084423A3 (de) | Wirkstoffkombinationen aus glucosylglyceriden und einem oder mehreren milden tensiden | |
WO2007034009A3 (es) | Utilización de acido masónico como antiparasitario frente a protozoos del phyllum apicomplexa | |
WO2010042685A3 (en) | Inhibitors of the atb(0,+) transporter and uses thereof | |
WO2010097501A3 (en) | A combination treatment of stroke | |
TW200501957A (en) | Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin Ⅱ antagonist for stroke prevention | |
WO2010126260A3 (ko) | 라이소포스파티드산 및 아데닐일 시클라아제 억제제를 유효성분으로 포함하는 상처 치유 촉진용 약학 조성물 | |
GB0616939D0 (en) | Test for the detection of active enzyme systems in human or animal bodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 06819972 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06819972 Country of ref document: EP Kind code of ref document: A2 |